Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biling Weitong Granules plus pantoprazole for peptic ulcer
ChiCTR1900022749Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Nanchang University
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of biling weitong granules, pantoprazole and Placebo-COD Research Private Ltd in Peptic ulcer disease (PUD) (2 arms), sponsored by First Affiliated Hospital of Nanchang University. Primary endpoints: Endoscopic mucosal healing area and Pain intensity and frequency VAS score. Planned start Apr 2018; status: not yet recruiting.
02
Drugs
biling weitong granulespantoprazolePlacebo-COD Research Private Ltd
03
Conditions
Peptic ulcer disease (PUD)
Beyond the preview
Go deeper on ChiCTR1900022749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022749.